TradingView
MarketMoversReport
May 12, 2022 5:32 PM
MediWound Announces Positive Results from Its U.S. Phase 2 Trial
Long
NASDAQ:MDWD
1D
MediWound Ltd.
NASDAQ
Description
⋅
May 12, 2022 5:32 PM
MDWD: MediWound Ltd.
2022-05-12 07:00:00
MediWound Announces Positive Results from Its U.S. Phase 2 Trial of EscharEx for Debridement of Chronic Wounds
Beyond Technical Analysis
More